AbbVie Ups Its IBD Game With Latest Crohn’s Data For Rinvoq

Last Of Three Phase III Readouts Also Positive

Chain of arrows blocks
Crohn's disease is an important building block in AbbVie's Rinvoq strategy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D